Invention Grant
- Patent Title: Inhibitors of the chemokine receptor CxCR3
- Patent Title (中): 趋化因子受体CxCR3的抑制剂
-
Application No.: US12852076Application Date: 2010-08-06
-
Publication No.: US08268828B2Publication Date: 2012-09-18
- Inventor: David Squire Thorpe , Martin Smrcina , Dagmar Dasha Cabel
- Applicant: David Squire Thorpe , Martin Smrcina , Dagmar Dasha Cabel
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agent Ronald G. Ort; Barbara E. Kurys
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/496 ; C07D295/185 ; C07D295/033 ; A61K31/48 ; C07D471/10

Abstract:
This invention is directed to a 3-(amido or sulphamido)-4-(4-substituted-azinyl)benzamide or benzsulphonamide compound as defined herein. The 3-(amido or sulphamido)-(4-substituted-azinyl)benzamide or benzsulphonamide compound is useful as a inhibitor of the chemokine receptor CxCR3, and for preventing or treating a CxCR3 chemokine receptor mediated disease or condition related thereto in a patient in need of such.
Public/Granted literature
- US20100305088A1 INHIBITORS OF THE CHEMOKINE RECEPTOR CxCR3 Public/Granted day:2010-12-02
Information query